Breuer K et al. |
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. |
2005 |
Am J Clin Dermatol |
pmid:15799678
|
Kalavala M and Dohil MA |
Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. |
2011 |
Am J Clin Dermatol |
pmid:21067248
|
Yang LP and Curran MP |
Spotlight on topical pimecrolimus in pediatric atopic dermatitis. |
2010 |
Am J Clin Dermatol |
pmid:20509720
|
Cheer SM and Plosker GL |
Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. |
2001 |
Am J Clin Dermatol |
pmid:11770393
|
Ozden MG et al. |
Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study. |
2010 |
Am J Clin Dermatol |
pmid:20000875
|
Patel TS et al. |
Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians. |
2007 |
Am J Clin Dermatol |
pmid:17645374
|
Mertens JS et al. |
Morphea and Eosinophilic Fasciitis: An Update. |
2017 |
Am J Clin Dermatol |
pmid:28303481
|
Frankel HC and Qureshi AA |
Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. |
2012 |
Am J Clin Dermatol |
pmid:22263704
|
Iskedjian M et al. |
Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence. |
2004 |
Am J Clin Dermatol |
pmid:15301573
|
Kroft EB et al. |
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. |
2009 |
Am J Clin Dermatol |
pmid:19354332
|
Siegfried EC et al. |
Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. |
2013 |
Am J Clin Dermatol |
pmid:23703374
|
Tjioe M et al. |
Topical macrolide immunomodulators: a role in the treatment of vitiligo? |
2006 |
Am J Clin Dermatol |
pmid:16489839
|
Valdivielso-Ramos M et al. |
Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA. |
2008 |
Am J Clin Dermatol |
pmid:18429647
|
Wellington K and Noble S |
Pimecrolimus: a review of its use in atopic dermatitis. |
2004 |
Am J Clin Dermatol |
pmid:15663345
|
Cook BA and Warshaw EM |
Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. |
2009 |
Am J Clin Dermatol |
pmid:19222250
|
Ingram JR et al. |
Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis. |
2009 |
Am J Clin Dermatol |
pmid:19489656
|
Reitamo S et al. |
Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. |
2002 |
Am J Clin Dermatol |
pmid:12113647
|
Wellington K and Jarvis B |
Spotlight on topical pimecrolimus in atopic dermatitis. |
2002 |
Am J Clin Dermatol |
pmid:12113651
|
Ellis CN et al. |
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of age. |
2006 |
Am J Clin Dermatol |
pmid:16605293
|
Kasper RC et al. |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease. |
2001 |
Am J Dermatopathol |
pmid:11285407
|